Heart drug digoxin tested as potential ALS treatment
NCT ID NCT07047209
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether digoxin, a heart medication, is safe and tolerable for people with ALS. It also looks at whether digoxin can slow nerve damage. About 40 adults with early-stage ALS will take digoxin for 24 weeks. The goal is to find a new way to manage this disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MGH
Boston, Massachusetts, 02114, United States
-
Northwestern Universsity
Chicago, Illinois, 60611, United States
-
Nova Southeastern University
Davie, Florida, 33314, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain implant aims to give voice to those trapped in silence
- Nasal spray aims to tame brain inflammation in ALS
- Robotic arm could help people with paralysis regain independence at home
- Experimental cell therapy tested in 3 ALS patients
- Gene therapy injection hopes to slow ALS
- Super-Sharp brain scanner could revolutionize diagnosis of dementia and cancer